Development and validation of a new risk assessment model for immunomodulatory drug-associated venous thrombosis among Chinese patients with multiple myeloma

BACKGROUND: Individuals with multiple myeloma (MM) receiving immunomodulatory drugs (IMiDs) are at risk of developing venous thromboembolism (VTE), a serious complication. There is no established clinical model for predicting VTE in the Chinese population. We develop a new risk assessment model (RAM...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xiaozhe, Sun, Xiuli, Fang, Baijun, Leng, Yun, Sun, Fangfang, Wang, Yaomei, Wang, Qing, Jin, Jie, Yang, Min, Xu, Bing, Fang, Zhihong, Chen, Lijuan, Chen, Zhi, Yang, Qimei, Zhang, Kejie, Ye, Yinhai, Geng, Hui, Sun, Zhiqiang, Hao, Dan, Huang, Hongming, Wang, Xiaotao, Jing, Hongmei, Ma, Lan, Pan, Xueyi, Chen, Wenming, Li, Juan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10552366/
https://www.ncbi.nlm.nih.gov/pubmed/37794471
http://dx.doi.org/10.1186/s12959-023-00534-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10552366/
https://www.ncbi.nlm.nih.gov/pubmed/37794471
http://dx.doi.org/10.1186/s12959-023-00534-y

Ejemplares similares